| 時間 | 主題 | ||||
|---|---|---|---|---|---|
PD04-1: Active surveillance in Taiwanese men with localized prostate cancer: Outcomes and predicting models
講者:
查舫宇
座長:
楊啟瑞, 王賢祥 |
查舫宇 |
楊啟瑞, 王賢祥 |
|||
PD04-2: Overall survival with Darolutamide versus placebo in combination with androgen-deprivation therapy and Docetaxel for metastatic hormone-sensitive prostate cancer in the phase 3 ARASENS trial
講者:
馮思中
座長:
楊啟瑞, 王賢祥 |
馮思中 |
楊啟瑞, 王賢祥 |
|||
PD04-3: The role of urine metabolomics in predicting clinically significant prostate cancer
講者:
陳忠信
座長:
楊啟瑞, 王賢祥 |
陳忠信 |
楊啟瑞, 王賢祥 |
|||
PD04-4: Comparison of the clinical outcomes of chemotherapy and novel hormone agents in pre-chemotherapy and post-chemotherapy settings for treatment of metastatic castration-resistant prostate cancer
講者:
吳芃諺
座長:
楊啟瑞, 王賢祥 |
吳芃諺 |
楊啟瑞, 王賢祥 |
|||
PD04-5: Prostate health index density outperforms prostate health index in clinically significant prostate cancer detection
講者:
蔣智宏
座長:
楊啟瑞, 王賢祥 |
蔣智宏 |
楊啟瑞, 王賢祥 |
|||
PD04-6: 4-year experience in CMUH for learning curve of MRI/Ultrasound fusion-guided prostate biopsy
講者:
李柏毅
座長:
楊啟瑞, 王賢祥 |
李柏毅 |
楊啟瑞, 王賢祥 |